Category: 2018-1

THE FRENCH APPROACH TO FIGHTING ANTIBIOTIC RESISTA...

Posted by admin | May 19, 2017 | 1, 2016, 2016 frontpage, Government engagement | 0

Register now

Posted by admin | May 19, 2017 | Uncategorized | 0

“Is that all?” Very little investment needed to sa...

Posted by admin | Sep 17, 2016 | Introduction | 0

Welcome

Posted by admin | Jul 11, 2016 | Introduction | 0

Introduction by Jean Carlet

Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0

2017

Using quality improvement to address hospital-acquired infections and antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0

Leighann E Kimble, Healthcare Improvement Fellow, quality & performance institute, University Research Co., LLC, USAID applying science to strengthen and improve systems (ASSIST) Project; Dr M Rashad Massoud, Chief Medical...

Governance against Antimicrobial Resistance in Africa: Confronting AMR when resources are limited – The example of Senegal

by admin | Jul 26, 2017 | 2017, 2017 - 2, Governance | 0
Less than one cent to save a patient from AMR?

by admin | Sep 21, 2017 | Supporters 2017 | 0
On the value of viewing Antimicrobial Resistance as a threat to international security

by admin | Jul 31, 2017 | 2017, Governance | 0

Economics and Innovation

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

2017

MedTech Europe

May 19, 2018

Institut Merieux

Institut Merieux

May 19, 2018

Less than one cent to save a patient fro...

Sep 21, 2017

A National Action Plan to Contain Antimi...

Sep 14, 2017

MedTech Europe

Sep 5, 2017

The Global Point Prevalence Survey – Biomérieux and Antwerp University Renew Their Commitment to Combat Antimicrobial Resistance

The Global Point Prevalence Survey ̵...

Jul 28, 2017

Because taking care is the essence of healthcare

Because taking care is the essence of he...

Jul 28, 2017

Healthcare

Improving rational antibiotic treatment of common childhood conditions in Uganda

by admin | Jul 31, 2017 | 2017, Healthcare | 0

Dr Tamar Chitashvili, Md, Senior Improvement Advisor, University Research Co., Llc, Uganda; Dr Ekaterine Cherkezishvili, Md, Mph, Research Consultant, University Research Co., Llc, Uganda; Dr Esther Karamagi, Md, Mbchb, Msc,...

Infections in surgery – a key battleground to combat antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0
Potential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections

by admin | Aug 1, 2017 | 2017, Healthcare | 0
Using quality improvement to address hospital-acquired infections and antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0

Economics and Innovation

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

All

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en milieu de soins

by admin | Feb 18, 2019 | 4f | 0

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en...

Mise en place d’un laboratoire de bactériologie médicale à Madagascar : expérience du CHU de Befelatanana, Antananarivo

by admin | Feb 18, 2019 | 3f | 0
La Résistance aux Antibiotiques au Liban

by admin | Feb 18, 2019 | 2f | 0
Antimicrobial Resistance (AMR): stressing the role of the health industry

by admin | Feb 18, 2019 | SF1 | 0

All
Diagnostics
Rational use of antibiotics

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en milieu de soins

by admin | Feb 18, 2019 | 4f

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en...

Mise en place d’un laboratoire de bactériologie médicale à Madagascar : expérience du CHU de Befelatanana, Antananarivo

by admin | Feb 18, 2019 | 3f
La Résistance aux Antibiotiques au Liban

by admin | Feb 18, 2019 | 2f
Antimicrobial Resistance (AMR): stressing the role of the health industry

by admin | Feb 18, 2019 | SF1
La Gouvernance Contre la Résistance aux Antimicrobiens en Afrique : Faire Face Quand les Ressources Sont Limitées, L’exemple Du Sénégal

by admin | Feb 18, 2019 | 1f, 2018 frontpage français

Augmented* medicine for all

by admin | Jul 19, 2016 | Diagnostics, Sponsored features

Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...

Diagnostics come of age to combat antimicrobial resistance

by admin | Jul 19, 2016 | Diagnostics, Sponsored features
Diagnostic innovation for antimicrobial resistance

by admin | Jul 11, 2016 | Diagnostics
Medical value of the rapid MRSA/SA screening in emergency surgery

by admin | Jul 11, 2016 | Diagnostics

The evolution of the global antibiotic resistance partnership

by admin | Sep 12, 2016 | Rational use of antibiotics

Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...

The global definition of responsible antibiotic use: Three highlights

by admin | Sep 9, 2016 | Rational use of antibiotics
The global definition of responsible antibiotic use: the drive-ab project

by admin | Jul 12, 2016 | Rational use of antibiotics

Sponsored Features

Becton, Dickinson and Company

Hindustan Syringes & MedicalDevice, India

MedTech Europe

Institut Mérieux

Categories

2016 (21)
- AMR and ICT (1)
- AMR and Tuberculosis (2)
- AMR in food, water and the environment (3)
- Diagnostics (4)
- Government engagement (3)
- Infection prevention and control (5)
- Rational use of antibiotics (3)
2016 frontpage (4)
- 1 (1)
- 2 (1)
- 3 (1)
- 4 (1)
2017 (38)
- Alternatives to Antibiotics (2)
- Economics and Innovation (4)
- Governance (8)
- Healthcare (8)
- One Health (7)
- Supporters 2017 (6)
2017 frontpage (4)
- 2017 – 1 (1)
- 2017 – 2 (1)
- 2017 – 3 (1)
- 2017 – 4 (1)
2018 frontpage (5)
- 2018-1 (1)
- 2018-2 (1)
- 2018-3 (1)
- 2018-4 (1)
- SF1 (1)
2018 frontpage français (4)
- 1f (1)
- 2f (1)
- 3f (1)
- 4f (1)
Introduction (4)
R&D innovation (5)
Sponsored features (6)
Supporters (3)
Uncategorized (1)

Global Health Dynamics

Cancer Control